The reason that we dont, as patients have ownership of our data, is because theres an arbitrage system where this data is bought and sold by various entities outside the patient, and theres a huge market and profitability incentive to keep this data away from patients ownership into the hands of these other entities, whether its the insurer, the PBM, the hospital system, the physician, the pharmacist, whatever it is
This negative chronotropic effect of PIA was rapidly reversed by addition of DPCPX
GLP-1 Medications, Metabolic Stress, and Antioxidant Status Semaglutide and tirzepatide reduce appetite through incretin pathways and slow gastric emptying, which can alter nutrient absorption and overall metabolic load during rapid weight loss
Compounded tirzepatide becomes a reasonable option when access barriers such as cost, insurance restrictions, or shortages prevent the use of FDA-approved Zepbound, provided you work with a qualified provider sourcing from a reputable 503B compounding facility